PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 162 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $17,322,000 | -36.8% | 2,470,965 | -17.2% | 0.04% | -36.9% |
| Q2 2021 | $27,411,000 | -22.2% | 2,985,976 | -17.7% | 0.06% | -29.3% |
| Q1 2021 | $35,251,000 | +0.6% | 3,626,637 | +6.2% | 0.09% | +1.1% |
| Q4 2020 | $35,048,000 | +4.2% | 3,416,003 | +2.5% | 0.09% | -7.1% |
| Q3 2020 | $33,625,000 | +30.3% | 3,332,523 | +34.7% | 0.10% | +15.3% |
| Q2 2020 | $25,804,000 | -34.5% | 2,474,029 | -47.0% | 0.08% | -2.3% |
| Q1 2020 | $39,414,000 | +154.3% | 4,669,934 | +163.7% | 0.09% | +52.6% |
| Q4 2019 | $15,498,000 | -13.6% | 1,771,185 | +6.3% | 0.06% | -18.6% |
| Q3 2019 | $17,942,000 | +18.9% | 1,666,679 | +40.4% | 0.07% | +20.7% |
| Q2 2019 | $15,086,000 | -67.3% | 1,186,936 | -0.3% | 0.06% | -68.5% |
| Q1 2019 | $46,186,000 | +176.1% | 1,190,675 | +44.8% | 0.18% | +139.0% |
| Q4 2018 | $16,729,000 | -59.5% | 822,041 | -8.8% | 0.08% | -50.3% |
| Q3 2018 | $41,319,000 | +81.5% | 901,182 | +134.2% | 0.16% | +61.5% |
| Q2 2018 | $22,763,000 | +29.1% | 384,838 | +48.6% | 0.10% | +17.1% |
| Q1 2018 | $17,627,000 | -6.6% | 259,023 | +35.7% | 0.08% | -3.5% |
| Q4 2017 | $18,874,000 | -15.8% | 190,935 | +2.0% | 0.08% | -19.0% |
| Q3 2017 | $22,407,000 | +23.3% | 187,118 | -10.0% | 0.10% | +20.7% |
| Q2 2017 | $18,169,000 | +64.2% | 207,884 | -30.1% | 0.09% | +58.2% |
| Q1 2017 | $11,064,000 | -50.2% | 297,414 | +215.8% | 0.06% | -45.0% |
| Q1 2015 | $22,233,000 | -43.2% | 94,166 | -54.4% | 0.10% | -46.8% |
| Q4 2014 | $39,122,000 | +1.3% | 206,698 | +27.7% | 0.19% | 0.0% |
| Q3 2014 | $38,625,000 | +162.1% | 161,904 | -27.5% | 0.19% | +157.5% |
| Q2 2014 | $14,737,000 | -0.7% | 223,290 | +56.6% | 0.07% | -1.4% |
| Q1 2014 | $14,846,000 | +18.4% | 142,557 | +17.7% | 0.07% | +15.6% |
| Q4 2013 | $12,535,000 | +17554.9% | 121,076 | +9003.5% | 0.06% | – |
| Q3 2013 | $71,000 | – | 1,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |